Patents by Inventor Tracy Fink

Tracy Fink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8246986
    Abstract: Aqueous drug coatings including at least one insoluble drug, wherein the insoluble drug accounts for about 85 wt % to about 97 wt % of the drug coatings are described. Such drug coatings may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: August 21, 2012
    Assignee: Alza Corporation
    Inventors: Evangeline Cruz, Gregory Ruhlmann, Brenda Pollock, Sherry Li, Carmelita Garcia, Alfredo M. Wong, Ryan Bronz, Tracy Fink, David Edgren
  • Patent number: 8226979
    Abstract: The present invention is directed to aqueous drug coatings that include at least one insoluble drug, wherein the drug accounts for about 85 wt % to about 97 wt % of the drug coatings. A drug coating according to the present invention may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs. The present invention also includes drug coating formulations suitable for providing drug coatings according to the present invention and dosage forms that include a drug coating according to the present invention.
    Type: Grant
    Filed: April 11, 2011
    Date of Patent: July 24, 2012
    Assignee: Alza Corporation
    Inventors: Evangeline Cruz, Gregory Ruhlmann, Brenda Pollock, Sherry Li, Carmelita Garcia, Alfredo M. Wong, Ryan Bronz, Tracy Fink, David Edgren
  • Publication number: 20120165361
    Abstract: The present invention is directed to aqueous drug coatings that include at least one insoluble drug, wherein the drug accounts for about 85 wt % to about 97 wt % of the drug coatings. A drug coating according to the present invention may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs. The present invention also includes drug coating formulations suitable for providing drug coatings according to the present invention and dosage forms that include a drug coating according to the present invention.
    Type: Application
    Filed: March 6, 2012
    Publication date: June 28, 2012
    Inventors: Evangeline Cruz, Gregory Ruhlmann, Brenda Pollock, Sherry Li, Carmelita Garcia, Alfredo M. Wong, Ryan Bronz, Tracy Fink, David Edgren
  • Publication number: 20110318392
    Abstract: The present invention is directed to aqueous drug coatings that include at least one insoluble drug, wherein the drug accounts for about 85 wt % to about 97 wt % of the drug coatings. A drug coating according to the present invention may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs. The present invention also includes drug coating formulations suitable for providing drug coatings according to the present invention and dosage forms that include a drug coating according to the present invention.
    Type: Application
    Filed: April 11, 2011
    Publication date: December 29, 2011
    Inventors: Evangeline Cruz, Gregory Ruhlmann, Brenda Pollock, Sherry Li, Carmelita Garcia, Alfredo M. Wong, Ryan Bronz, Tracy Fink, David Edgren
  • Publication number: 20050112195
    Abstract: The present invention is directed to aqueous drug coatings that include at least one insoluble drug, wherein the drug accounts for about 85 wt % to about 97 wt % of the drug coatings. A drug coating according to the present invention may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs. The present invention also includes drug coating formulations suitable for providing drug coatings according to the present invention and dosage forms that include a drug coating according to the present invention.
    Type: Application
    Filed: September 23, 2004
    Publication date: May 26, 2005
    Inventors: Evangeline Cruz, Gregory Ruhlmann, Brenda Pollock, Sherry Li, Carmelita Garcia, Alfredo Wong, Ryan Bronz, Tracy Fink, David Edgren
  • Publication number: 20040010000
    Abstract: Dosage forms and methods for the controlled release of oxycodone over a prolonged period of time are described. The sustained release dosage forms provide therapeutically effective average steady-state plasma oxycodone concentrations when administered once per day. This once-a-day dosing regimen results in only one peak plasma oxycodone concentration occurrence in each 24 hour period that occurs at a later time after administration and exhibits a lesser magnitude than the peak plasma oxycodone concentration that occurs following administration of oxycodone in an immediate-release dosage form and other prior art extended release dosage forms.
    Type: Application
    Filed: April 25, 2003
    Publication date: January 15, 2004
    Inventors: Atul D. Ayer, Padmaja Shivanand, Nishit B. Modi, Sonya Seroff, Michael A. DesJardin, Tracy A. Fink, Linda M. Hearney, Deborah J. Johnson, Clark P. Allphin
  • Publication number: 20030224051
    Abstract: Dosage forms, compositions and methods for the controlled release of oxycodone over a prolonged period of time are described. The present invention discloses a novel means for delivering varying doses of oxycodone using a drug composition having only oxycodone, a polymer carrier and varying amounts of salt to provide a particular viscosity of the hydrated drug core for delivery of the drug at the desired release rate. The present invention functions by modulating the viscosity of the hydrated drug layer in operation by the addition or reduction of salts in the drug composition. The system is independent of solubility enhancers or pH modifiers. The sustained release dosage forms provide therapeutically effective average steady-state plasma oxycodone concentrations when administered once per day.
    Type: Application
    Filed: May 28, 2003
    Publication date: December 4, 2003
    Inventors: Tracy A. Fink, Atul D. Ayer, Deborah J. Johnson, Padmaja Shivanand, Clark P. Allphin